Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 4:01 pm Sale | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 481,727 4.68% | -117,470 (-19.60%) | View |
| 2024-03-20 9:07 pm Sale | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 599,197 5.83% | -90,372 (-13.11%) | View |
| 2024-03-20 4:37 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | GKCC LLC | 2,043,180 19.99% | 123,016 (+6.41%) | View |
| 2023-12-27 4:07 pm Unchanged | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 7.12% | 0 (Unchanged) | View |
| 2023-12-26 4:25 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | GKCC LLC | 1,920,164 19.99% | 1,213,000 (+171.53%) | View |
| 2023-08-30 5:16 pm Unchanged | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 8.16% | 0 (Unchanged) | View |
| 2023-07-07 09:17 am Purchase | 13G | ELICIO THERAPEUTICS INC ELTX | Vifor (International) Ltd | 199,564 0.02% | 199,564 (New Position) | View |
| 2023-06-14 4:04 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | Elicio Therapeutics Inc. ELTX | 319,527 3.7% | 319,527 (New Position) | View |
| 2023-06-14 2:42 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | GKCC LLC | 707,164 8.4% | 707,164 (New Position) | View |
| 2023-06-12 4:01 pm Purchase | 13D | ELICIO THERAPEUTICS INC ELTX | Clal Biotechnology Industries Ltd. | 689,569 7.11% | 689,569 (New Position) | View |
| 2023-02-14 4:23 pm Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | Goldberg Itzhak | 1,809,294 6% | 1,809,294 (New Position) | View |
| 2023-02-14 12:12 pm Unchanged | 13G | ANGION BIOMEDICA CORP COM ANGN | EISA-ABC LLC | 1,722,237 5.7% | 0 (Unchanged) | View |
| 2023-02-10 4:53 pm Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | SATTERFIELD THOMAS A JR | 2,213,383 7.35% | 638,836 (+40.57%) | View |
| 2022-05-19 10:04 am Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | SATTERFIELD THOMAS A JR | 1,574,547 5.3% | 1,574,547 (New Position) | View |
| 2022-04-27 4:10 pm Sale | 13G | ANGION BIOMEDICA CORP COM ANGN | Elicio Therapeutics Inc. ELTX | 1,815,121 6% | -1,086,621 (-37.45%) | View |
| 2022-04-27 4:08 pm Purchase | 13D | ANGION BIOMEDICA CORP COM ANGN | Elicio Therapeutics Inc. ELTX | 2,901,742 9.3% | 2,901,742 (New Position) | View |
| 2022-03-30 3:51 pm Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | Vifor (International) Ltd | 1,995,643 6.7% | 1,995,643 (New Position) | View |
| 2022-02-14 5:29 pm Purchase | 13G | ANGION BIOMEDICA CORP COM ANGN | EISA-ABC LLC | 1,722,237 5.7% | 1,722,237 (New Position) | View |